{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-26-002787","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2026-05-19T10:03:08+00:00","discovered_at":"2026-05-19T10:10:00.240380+00:00","generated_at":"2026-05-19T10:10:43.854104+00:00","sec_items":["1.01","3.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"InMed amends Armistice option exercise price from $16.60 to $0.80 per share","bullets":["Up to 278,761 common shares subject to options; exercise price reduced to $0.80 from $16.60.","Options originally issued October 26, 2023; amendment entered May 18, 2026.","Dramatic price reduction may increase dilution risk for existing shareholders if exercised.","Press release issued May 19, 2026 confirms amendment; no assurance options will be exercised."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002787","json":"https://secwatch.observer/filing/0001062993-26-002787.json","markdown":"https://secwatch.observer/filing/0001062993-26-002787.md","text":"https://secwatch.observer/filing/0001062993-26-002787.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/0001062993-26-002787-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:10:43.854104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cff8f74494f8b4eea786a178fe2f6b95dc2e462f","claim":"InMed Pharmaceuticals Inc. amended Armistice Preferred Investment Option Amending Agreement with Armistice Capital Master Fund Ltd. (effective 2026-05-18).","evidence_excerpt":"On May 18, 2026, the Company entered into a preferred investment option amending agreement (the \"Armistice Preferred Investment Option Amending Agreement\") with Armistice to amend the Armistice Exercise Price contained in the Armistice Preferred Investment Options from $16.60 to $0.80.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1728328/000106299326002787/0001062993-26-002787-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Armistice Capital Master Fund Ltd."},{"label":"Effective","value":"2026-05-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}